[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Alnylam Pharmaceuticals, Inc. Graphic](https://lunarcrush.com/gi/w:26/t:alnylam-pharmaceuticals-inc.png) Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals (ALNY) stock is experiencing a breakout with positive sentiment, despite an FDA crackdown and ad pull. Truist Securities sees a strong sector rebound and raises ALNY's price target to $XXX.

### About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.  
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/alnylam-pharmaceuticals-inc/insights)
- Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) galaxy score™ is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) sentiment is up XXXXX% from the previous month.
- Alnylam Pharmaceuticals, Inc. (ALNY) creators is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) mentions is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) posts created is up XX% from the previous week.
- Alnylam Pharmaceuticals, Inc. Price hit a 52-Week high of XXXXXX for the hour
- Alnylam Pharmaceuticals, Inc. Price hit an all time of XXXXXX for the hour

### Price: $XXXXXX [#](/topic/alnylam-pharmaceuticals-inc/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is experiencing volatility due to mixed news. Positive data from the HELIOS-B study and strong sales are countered by the ad pull and negative sentiment on X, leading to a balanced outlook. The 24-hour price change is 0.1%, while the 7-day change is 0.9%, and the 30-day change is -1.17%.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXX%   |

**1-Year High**: $XXXXXX on 2025-09-09  
**1-Year Low**: $XXXXXX on 2025-04-08  
  
  
### AltRank: XXXXX [#](/topic/alnylam-pharmaceuticals-inc/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/alt_rank.tsv)  
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #1,719 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXXXX +640  
**6 Months**: XXXXX +1,394  
**1 Year**: XXXXX +1,446  
**1-Year High**: XXXXX on 2025-06-26  
**1-Year Low**: X on 2025-03-22  
  
  
### Galaxy Score: XXXXX [#](/topic/alnylam-pharmaceuticals-inc/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +32  
**1 Month**: XX +5  
**6 Months**: XX +4  
**1 Year**: XX +9  
**1-Year High**: XX on 2025-02-19  
**1-Year Low**: XX on 2025-06-26  
  
  
### Engagements: XXXXXX [#](/topic/alnylam-pharmaceuticals-inc/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +9.10%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +28%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-03-21  
**1-Year Low**: XXXXX on 2025-10-12  

| Social Network | X      | News | YouTube |
| -------------- | -      | ---- | ------- |
| Engagements    | XXXXXX | X    | X       |
  

  
  
### Mentions: XXX [#](/topic/alnylam-pharmaceuticals-inc/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX +21%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +11%  
**1 Year**: XXXXX -XXXX%  
**1-Year High**: XXX on 2024-11-28  
**1-Year Low**: XX on 2025-10-19  

| Social Network | X   | News | YouTube |
| -------------- | -   | ---- | ------- |
| Mentions       | XXX | X    | X       |
  

  
  
### Creators: XX [#](/topic/alnylam-pharmaceuticals-inc/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XXXX% from XX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XX +25%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +86%  
**1 Year**: XXXXX +70%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-01-27  

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@Biobeats99](/creator/twitter/Biobeats99)         | X    | XXX       | XX    | XXX         |
| [@semodough](/creator/twitter/semodough)           | X    | XXXXXX    | X     | XXX         |
| [@sssc](/creator/twitter/sssc)                     | X    | XXXXX     | X     | XXX         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)       | X    | XXXXXX    | X     | XXX         |
| [@Longroaderstar](/creator/twitter/Longroaderstar) | X    | XXX       | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)         | X    | XXXXX     | X     | XXX         |
| [@PaulMarganski](/creator/twitter/PaulMarganski)   | X    | XX        | X     | XXX         |
| [@Markadiusz45](/creator/twitter/Markadiusz45)     | X    | XXX       | X     | XX          |
| [@occams_tooth](/creator/twitter/occams_tooth)     | X    | XXX       | X     | XX          |
| [@IBDinvestors](/creator/twitter/IBDinvestors)     | XX   | XXXXXXX   | X     | XX          |

[View More](/list/creators/alnylam-pharmaceuticals-inc/100)
  
  
### Sentiment: XX% [#](/topic/alnylam-pharmaceuticals-inc/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +11%  
**1 Month**: XX% +21%  
**6 Months**: XX% +35%  
**1 Year**: XX% +5%  
**1-Year High**: XXX% on 2025-07-29  
**1-Year Low**: XX% on 2025-05-28  

**Most Supportive Themes**
- **Positive Data from HELIOS-B Study:** (35%) New data from the HELIOS-B Phase X study demonstrates lower rates of gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its role as a first-line therapy.
- **Amvuttra Sales and Revenue Guidance:** (20%) Alnylam reported strong Amvuttra sales and raised its 2025 revenue guidance, indicating positive financial performance.
- **First Patient Dosed in ZENITH Trial:** (15%) Alnylam announced the first patient dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, signaling progress in its clinical pipeline.
  
**Most Critical Themes**
- **FDA Crackdown and Ad Pull:** (10%)  Alnylam pulled TV ads following a crackdown on drug industry advertising, which may raise concerns.
- **Negative Sentiment on X:** (20%)  A large percentage of X posts express negative sentiment, with many users expressing concerns about the company.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/alnylam-pharmaceuticals-inc/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.0091%  
**1 Month**: XXXXX% +0.014%  
**6 Months**: XXXXX% -XXXXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-11-06  
**1-Year Low**: XXXXXX% on 2025-07-29  
  
  
### Market Dominance: XXXXX% [#](/topic/alnylam-pharmaceuticals-inc/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-09-09  
**1-Year Low**: XXXXX% on 2025-01-06  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/alnylam-pharmaceuticals-inc/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$5.30%  
**1 Month**: $XXXXXXXXXXXXXX +$6.50%  
**6 Months**: $XXXXXXXXXXXXXX +$110%  
**1 Year**: $XXXXXXXXXXXXXX +$66%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-09-09  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Intellia Therapeutics, Inc (NTLA)](/topic/$ntla)
[BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn)
[Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Arrowhead Research Corporation (ARWR)](/topic/$arwr)
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl)

**Top topics mentioned**
In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [$bbio](/topic/$bbio), [$pfe](/topic/$pfe), [investment](/topic/investment), [stocks financial services](/topic/stocks-financial-services), [$ntla](/topic/$ntla), [stocks](/topic/stocks), [coins defi](/topic/coins-defi), [stocks industrials](/topic/stocks-industrials), [coins base ecosystem](/topic/coins-base-ecosystem), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$bmrn](/topic/$bmrn), [$ions](/topic/$ions), [johnson johnson](/topic/johnson-johnson), [$arwr](/topic/$arwr), [coins dao](/topic/coins-dao), [telegram](/topic/telegram), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$mdgl](/topic/$mdgl), [stocks banks](/topic/stocks-banks), [$mrk](/topic/$mrk), [$jnj](/topic/$jnj), [$qure](/topic/$qure), [dough](/topic/dough), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$insm](/topic/$insm), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$argx](/topic/$argx), [$adhcon](/topic/$adhcon), [$ge](/topic/$ge), [stocks defense](/topic/stocks-defense), [$orcl](/topic/$orcl), [$sln](/topic/$sln), [$imvt](/topic/$imvt), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$amgn](/topic/$amgn), [bitmine](/topic/bitmine), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$rytm](/topic/$rytm), [has been](/topic/has-been), [stocks utilities](/topic/stocks-utilities), [$incy](/topic/$incy), [$xene](/topic/$xene), [$atyr](/topic/$atyr), [money](/topic/money), [stocks basic materials](/topic/stocks-basic-materials), [bears](/topic/bears), [$xbi](/topic/$xbi), [$rvmd](/topic/$rvmd), [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc), [advanced micro devices](/topic/advanced-micro-devices), [stocks energy](/topic/stocks-energy), [coins bsc](/topic/coins-bsc), [$tdoc](/topic/$tdoc), [$hca](/topic/$hca), [$uhs](/topic/$uhs), [$cyh](/topic/$cyh), [$ahr](/topic/$ahr), [$alab](/topic/$alab), [reit](/topic/reit), [$oklo](/topic/$oklo), [$zepp](/topic/$zepp), [$ecl](/topic/$ecl), [$ferg](/topic/$ferg), [$be](/topic/$be), [$dy](/topic/$dy), [$cien](/topic/$cien), [$eypt](/topic/$eypt), [$ocul](/topic/$ocul), [nasdaq](/topic/nasdaq), [vertex protocol](/topic/vertex-protocol), [cloudflare](/topic/cloudflare), [$cdtx](/topic/$cdtx), [$ctmx](/topic/$ctmx), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$mp](/topic/$mp), [$adhc](/topic/$adhc), [$adhc0015](/topic/$adhc0015), [$adhcfda](/topic/$adhcfda), [$regn](/topic/$regn), [$tln](/topic/$tln), [$nvo](/topic/$nvo), [$tr](/topic/$tr), [$aeis](/topic/$aeis), [gilead sciences](/topic/gilead-sciences), [$50b](/topic/$50b), [$vktx](/topic/$vktx), [sofi technologies](/topic/sofi-technologies), [dd](/topic/dd), [$rna](/topic/$rna), [$alnys](/topic/$alnys), [what a](/topic/what-a), [$abbv](/topic/$abbv), [$eqix](/topic/$eqix), [sanofi](/topic/sanofi), [$92b](/topic/$92b), [crowdstrike](/topic/crowdstrike), [albemarle corp](/topic/albemarle-corp), [$alb](/topic/$alb)

### Top Social Posts [#](/topic/alnylam-pharmaceuticals-inc/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"All three are great opportunities. Just because $ALNY is up a lot doesn't mean it can't go higher. They will be generating $10s of dollars per share in EBITA. Even a PE of XX will drive this well past $500-$700 over the next few years"  
[X Link](https://x.com/paulBIOgeek/status/1979705978586313080) [@paulBIOgeek](/creator/x/paulBIOgeek) 2025-10-19T00:27Z XXX followers, XX engagements


"Cantor Fitzgerald Cantor/KURA: FTI is Coming Back at ESMO Full report in Telegram (in bio)👆 $KURA $ARWR $ALNY $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR $ZLAB $EXEL"  
[X Link](https://x.com/Biobeats99/status/1979671378384338998) [@Biobeats99](/creator/x/Biobeats99) 2025-10-18T22:10Z XXX followers, XXX engagements


"Minervini "Trend Template" Screener XX Stocks $HI $BG $INTC $WDC $VRDN $COGT $OKLO $ZGN $ELAN $SIG $MNMD $XERS $NUVL $ATAI $ESTA $CRL $EDU $FIGS $EL $WULF $MTRN $VCYT $CELH $BKD $BTSG $DK $IDYA $NTRA $PII $AXSM $SLDP $WK $COHR $BBY $ROCK $PRM $ALNY $CLDX $ASND $PI $GXO $IRTC $LUV Criteria: Minervini Trend Template + Green Candle (Chg =0 Open Chg =0) + $1B+ Market Cap The market cap has been limited to $1B+ for liquidity purposes This screener is inspired by the eight criteria "Trend Template" described by the ever excellent Mark Minervini in his classic book "Trade Like a Stock Market Wizard""  
[X Link](https://x.com/SteveDJacobs/status/1979633561713184955) [@SteveDJacobs](/creator/x/SteveDJacobs) 2025-10-18T19:39Z 5888 followers, 1072 engagements


"Bank of America AGIO US: Agios Pharmaceuticals - Positive CHMP opinion bolsters confidence in global approvals - BUY Full report in Telegram (in bio)👆 $AGIO $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE"  
[X Link](https://x.com/Biobeats99/status/1979607196645384305) [@Biobeats99](/creator/x/Biobeats99) 2025-10-18T17:55Z XXX followers, XXX engagements